Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.33 |
| ▸ | CDK4 | P11802 | 11/20 | 0.33 |
| ▸ | CDK6 | Q00534 | 9/20 | 0.33 |
| ▸ | CCND3 | P30281 | 6/20 | 0.33 |
| ▸ | CCND1 | P24385 | 5/20 | 0.33 |
| ▸ | CDK2 | P24941 | 5/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.32 |
| ▸ | CDK1 | P06493 | 2/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.31 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650586 | 0.89 | EGFR (0.39) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL22650829 | 0.78 | CDK4 (0.34) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL22650828 | 0.78 | CDK4 (0.33) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL22650721 | 0.75 | SMN1; SMN2 (0.34) | CDK4CDK6CCND3CCND1CDK2 | |
| SCHEMBL22650399 | 0.74 | CDK4 (0.33) | CDK4CDK6CCND3CCND1CDK2 | |
| SCHEMBL22650727 | 0.74 | ALDH1A1 (0.33) | ALDH1A1GAA | |
| SCHEMBL22650826 | 0.72 | AAK1 (0.38) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL22129294 | 0.71 | CDK4 (0.49) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL22129323 | 0.71 | CDK4 (0.49) | EGFRCDK4CDK6CCND3CCND1 | |
| SCHEMBL23749547 | 0.69 | CDK4 (0.47) | CDK4CDK6CCND3CCND1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |